Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
<h4>Background</h4>Ovarian Cancer (OC) stands as the most lethal gynecological malignancy, presenting an urgent clinical challenge in the quest to improve response rates. One approach to address this challenge is through drug repurposing, exemplified by the investigation of metabolic-mod...
Main Authors: | Sara Mikhael, Abdullah Kurdi, Nathalie Khoueiry-Zgheib, Roula Tahtouh, Rihab Nasr, George Hilal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298127&type=printable |
Similar Items
-
Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation
by: Rita Aoun, et al.
Published: (2022-03-01) -
Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection
by: Farah J. Nassar, et al.
Published: (2020-02-01) -
Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
by: Stephanie Antoun, et al.
Published: (2018-01-01) -
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma
by: Adèle Mangelinck, et al.
Published: (2021-11-01) -
Effect of Metformin and Simvastatin in Inhibiting Proadipogenic Transcription Factors
by: Jelena Jakab, et al.
Published: (2021-11-01)